The DOI matches its Crossref record; 674 of the 674 references it cites were found in a registry or an index.
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
Open accessAbstract
ObjectiveTo provide an update to the “Surviving Sepsis Campaign Guidelines for Management of Severe Sepsis and Septic Shock,” last published in 2008.DesignA consensus committee of 68 international experts representing 30 international organizations was convened. Nominal groups were assembled at key international meetings (for those committee members attending the conference). A formal conflict of interest policy was developed at the onset of the process and enforced throughout. The entire guidelines process was conducted independent of any industry funding. A stand-alone meeting was held for all subgroup heads, co- and vice-chairs, and selected individuals. Teleconferences and electronic-based discussion among subgroups and among the entire committee served as an integral part of the development.MethodsThe authors were advised to follow the principles of the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system to guide assessment of quality of evidence from high (A) to very low (D) and to determine the strength of recommendations as strong (1) or weak (2). The potential drawbacks of making strong recommendations in the presence of low-quality evidence were emphasized. Recommendations were classified into three groups: (1) those directly targeting severe sepsis; (2) those targeting general care of the critically ill patient and considered high priority in severe sepsis; and (3) pediatric considerations.ResultsKey recommendations and suggestions, listed by category, include: early quantitative resuscitation of the septic patient during the first 6 h after recognition (1C); blood cultures before antibiotic therapy (1C); imaging studies performed promptly to confirm a potential source of infection (UG); administration of broad-spectrum antimicrobials therapy within 1 h of the recognition of septic shock (1B) and severe sepsis without septic shock (1C) as the goal of therapy; reassessment of antimicrobial therapy daily for de-escalation, when appropriate (1B); infection source control with attention to the balance of risks and benefits of the chosen method within 12 h of diagnosis (1C); initial fluid resuscitation with crystalloid (1B) and consideration of the addition of albumin in patients who continue to require substantial amounts of crystalloid to maintain adequate mean arterial pressure (2C) and the avoidance of hetastarch formulations (1B); initial fluid challenge in patients with sepsis-induced tissue hypoperfusion and suspicion of hypovolemia to achieve a minimum of 30 mL/kg of crystalloids (more rapid administration and greater amounts of fluid may be needed in some patients (1C); fluid challenge technique continued as long as hemodynamic improvement is based on either dynamic or static variables (UG); norepinephrine as the first-choice vasopressor to maintain mean arterial pressure ≥65 mmHg (1B); epinephrine when an additional agent is needed to maintain adequate blood pressure (2B); vasopressin (0.03 U/min) can be added to norepinephrine to either raise mean arterial pressure to target or to decrease norepinephrine dose but should not be used as the initial vasopressor (UG); dopamine is not recommended except in highly selected circumstances (2C); dobutamine infusion administered or added to vasopressor in the presence of (a) myocardial dysfunction as suggested by elevated cardiac filling pressures and low cardiac output, or (b) ongoing signs of hypoperfusion despite achieving adequate intravascular volume and adequate mean arterial pressure (1C); avoiding use of intravenous hydrocortisone in adult septic shock patients if adequate fluid resuscitation and vasopressor therapy are able to restore hemodynamic stability (2C); hemoglobin target of 7–9 g/dL in the absence of tissue hypoperfusion, ischemic coronary artery disease, or acute hemorrhage (1B); low tidal volume (1A) and limitation of inspiratory plateau pressure (1B) for acute respiratory distress syndrome (ARDS); application of at least a minimal amount of positive end-expiratory pressure (PEEP) in ARDS (1B); higher rather than lower level of PEEP for patients with sepsis-induced moderate or severe ARDS (2C); recruitment maneuvers in sepsis patients with severe refractory hypoxemia due to ARDS (2C); prone positioning in sepsis-induced ARDS patients with a Pao2/Fio2 ratio of ≤100 mm Hg in facilities that have experience with such practices (2C); head-of-bed elevation in mechanically ventilated patients unless contraindicated (1B); a conservative fluid strategy for patients with established ARDS who do not have evidence of tissue hypoperfusion (1C); protocols for weaning and sedation (1A); minimizing use of either intermittent bolus sedation or continuous infusion sedation targeting specific titration endpoints (1B); avoidance of neuromuscular blockers if possible in the septic patient without ARDS (1C); a short course of neuromuscular blocker (no longer than 48 h) for patients with early ARDS and a Pao2/Fio2 <150 mm Hg (2C); a protocolized approach to blood glucose management commencing insulin dosing when two consecutive blood glucose levels are >180 mg/dL, targeting an upper blood glucose ≤180 mg/dL (1A); equivalency of continuous veno-venous hemofiltration or intermittent hemodialysis (2B); prophylaxis for deep vein thrombosis (1B); use of stress ulcer prophylaxis to prevent upper gastrointestinal bleeding in patients with bleeding risk factors (1B); oral or enteral (if necessary) feedings, as tolerated, rather than either complete fasting or provision of only intravenous glucose within the first 48 h after a diagnosis of severe sepsis/septic shock (2C); and addressing goals of care, including treatment plans and end-of-life planning (as appropriate) (1B), as early as feasible, but within 72 h of intensive care unit admission (2C). Recommendations specific to pediatric severe sepsis include: therapy with face mask oxygen, high flow nasal cannula oxygen, or nasopharyngeal continuous PEEP in the presence of respiratory distress and hypoxemia (2C), use of physical examination therapeutic endpoints such as capillary refill (2C); for septic shock associated with hypovolemia, the use of crystalloids or albumin to deliver a bolus of 20 mL/kg of crystalloids (or albumin equivalent) over 5–10 min (2C); more common use of inotropes and vasodilators for low cardiac output septic shock associated with elevated systemic vascular resistance (2C); and use of hydrocortisone only in children with suspected or proven “absolute”’ adrenal insufficiency (2C).ConclusionsStrong agreement existed among a large cohort of international experts regarding many level 1 recommendations for the best care of patients with severe sepsis. Although a significant number of aspects of care have relatively weak support, evidence-based recommendations regarding the acute management of sepsis and septic shock are the foundation of improved outcomes for this important group of critically ill patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 601–674 of 674
Zhou, S., Qiu, H., Huang, Y., Yang, Y., & Zheng, R. (2002) · PubMed · Cited by 52
The Use of Inotropic and Afterload-reducing Agents in Neonates
Keeley, S. R., & BOHN, D. J. (1988) · Clinics in Perinatology · doi:10.1016/s0095-5108(18)30692-4 · Cited by 51
Schultz, M. J. (2008) · PubMed · Cited by 51
PLASMAPHERESIS FOR FULMINANT MENINGOCOCCEMIA
Drapkin, M. S., Wisch, J. S., Gelfand, J. A., Cannon, J. G., & Dinarello, C. A. (1989) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-198906000-00015 · Cited by 51
Pongprasobchai, S., Kridkratoke, S., & Nopmaneejumruslers, C. (2009) · PubMed · Cited by 49
Avoiding Colectomy during Surgical Management of Fulminant Clostridium difficile Colitis
Olivas, A. D., Umanskiy, K., Zuckerbraun, B. S., & Alverdy, J. C. (2010) · Surgical Infections · doi:10.1089/sur.2010.026 · Cited by 49
Domico, M. B., Ridout, D. A., Bronicki, R. A., ANAS, N. G., Cleary, J. P., Cappon, J. P., Goldman, A. P., & Brown, K. (2011) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0b013e3182192c66 · Cited by 48
Hyperglycemia is associated with morbidity in critically ill children with meningococcal sepsis
Day, K. M., Haub, N., Betts, H., & Inwald, D. P. (2008) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0b013e31818d350b · Cited by 47
Cost Reduction and Outcome Improvement in the Intensive Care Unit
Marx, W. H., DeMaintenon, N. L., Mooney, K. F., Mascia, M. F., Medicis, J. J., Franklin, P. D., Sivak, E. D., & Rotello, L. C. (1999) · doi:10.1097/00005373-199904000-00011 · Cited by 47
Developing Quality Measures for Sepsis Care in the ICU
Berenholtz, S. M., Pronovost, P. J., Ngo, K., Barie, P. S., Hitt, J., Kuti, J. L., Septimus, E. J., Lawler, N. K., Schilling, L., & Dorman, T. (2007) · The Joint Commission Journal on Quality and Patient Safety · doi:10.1016/s1553-7250(07)33060-2 · Cited by 46
Plasma exchange therapy for thrombotic microangiopathies
Nguyen, T. C., & Han, Y. Y. (2011) · Organogenesis · doi:10.4161/org.7.1.14027 · Cited by 46
Akutes Nierenversagen bei abdomineller Sepsis
Mauritz, W., Sporn, P., Schindler, I., Zadrobilek, E., Roth, E., & Appel, W. (1986) · AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie · doi:10.1055/s-2007-1002472 · Cited by 46
Avenell, A. (2009) · Proceedings of The Nutrition Society · doi:10.1017/s0029665109001372 · Cited by 46
Kahn, J. M., Doctor, J. N., & Rubenfeld, G. D. (2006) · Intensive Care Medicine · doi:10.1007/s00134-006-0244-0 · Cited by 45
Self-citationFrankel, H. L., Jeng, J. Y., Tilly, E., Andre, A. S., & Champion, H. R. (1996) · PubMed · Cited by 44
Amado, V. M., Vilela, G. P., Queiroz, A. R. F. B., & Amaral, A. C. K.-B. (2010) · Journal of Critical Care · doi:10.1016/j.jcrc.2010.05.034 · Cited by 44
Brandtzaeg, P., Sirnes, K. E., Folsland, B., Godal, H. C., Kierulf, P., Bruun, J., & Dobloug, J. H. (1985) · PubMed · Cited by 43
Tilanus, A., de Geus, H. R. H., Rijnders, B. J. A., Dwarkasing, R. S., van der Hoven, B., & Bakker, J. (2009) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2009.07.014 · Cited by 43
Gurnani, P. K., Patel, G. P., Crank, C. W., Vais, D., Lateef, O., Akimov, S., BALK, R. A., & Simon, D. (2010) · Clinical Therapeutics · doi:10.1016/j.clinthera.2010.07.003 · Cited by 43
Haskamp, A. C., & Snyder, S. (2008) · Journal of Pediatric Oncology Nursing · doi:10.1177/1043454208319971 · Cited by 42
Stress ulcer prophylaxis in critically ill patients: review of the evidence
Alhazzani, W. A., Alshahrani, M. S. S., Moayyedi, P., & Jaeschke, R. (2012) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.1173 · Cited by 42
Self-citationHuh, J. W., CHOI, H., Lim, C., Koh, Y., Oh, Y., Shim, T. S., LEE, S. D., Kim, W. S., Kim, D. S., & Hong, S. (2011) · Respirology · doi:10.1111/j.1440-1843.2011.02018.x · Cited by 41
Treatment of septic thrombocytopenia with immune globulin
Burns, E. R., Lee, V., & Rubinstein, A. (1991) · Journal of Clinical Immunology · doi:10.1007/bf00918802 · Cited by 41
The Trials Management Group, Andrews, P. J., Avenell, A., Noble, D. W., Campbell, M., Battison, C. G., Croal, B. L., Simpson, W. G., Norrie, J. D., Vale, L. D., et al. (2007) · Trials · doi:10.1186/1745-6215-8-25 · Cited by 41
Amrinone in pediatric refractory septic shock: An open-label pharmacodynamic study
Irazuzta, J. E., Pretzlaff, R. K., & Rowin, M. E. (2001) · Pediatric Critical Care Medicine · doi:10.1097/00130478-200101000-00006 · Cited by 40
Bendjelid, K. (2005) · CHEST Journal · doi:10.1378/chest.128.5.3639 · Cited by 40
Pestaña, D., Espinosa, E., Sangüesa-Molina, J. R., Ramos, R., Pérez‐Fernández, E., Duque, M. G., & Martinez-Casanova, E. (2010) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0b013e3181c4539f · Cited by 38
Kong, M. Y. F., Alten, J. A., & Tofil, N. M. (2007) · Pediatric Critical Care Medicine · doi:10.1097/01.pcc.0000282778.86088.9d · Cited by 37
Gattinoni, L., Marcolin, R., Caspani, M. L., Fumagalli, R., MASCHERONI, D., & Pesenti, A. M. (1985) · PubMed · Cited by 36
Purpura fulminans in a Child as a Complication of Chickenpox Infection
Campanelli, A., Kaya, G., Ozsahin, A. H., Scala, G. C. L., Jacquier, C., Ettlin, M. S., Boehlen, F., de Moerloose, P., & Saurat, J. ‐. (2004) · Dermatology · doi:10.1159/000077315 · Cited by 35
[Levosimendan, a new inotropic drug: experience in children with acute heart failure].
Magliola, R., Moreno, G., Vassallo, J. C., Landry, L. M., Althabe, M., Balestrini, M. R., Charroqui, A., Salgado, G. H., Lataza, E., & Chang, A. C. (2009) · PubMed · doi:10.1590/s0325-00752009000200008 · Cited by 34
Hassen, M. F., Ayed, S., Gharbi, R., Ali, H. B. S., Marghli, S., & Elatrous, S. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.09.018 · Cited by 34
Gauvin, F., Dugas, M.-A., Chaïbou, M., Morneau, S., Lebel, D., & Lacroix, J. (2001) · Pediatric Critical Care Medicine · doi:10.1097/00130478-200110000-00002 · Cited by 34
Glycemic control and insulin therapy in sepsis and critical illness
Branco, R. G., Tasker, R. C., Garcia, P. C. R., Piva, J. P., & Xavier, L. D. (2007) · Jornal de Pediatria · doi:10.2223/jped.1710 · Cited by 34
Cardiac rescue with enoximone in volume and catecholamine refractory septic shock
Ringe, H., Varnholt, V., & Gaedicke, G. (2003) · Pediatric Critical Care Medicine · doi:10.1097/01.pcc.0000074275.61913.72 · Cited by 33
Airway pressure release ventilation: A pediatric case series
Krishnan, J., & Morrison, W. E. (2006) · Pediatric Pulmonology · doi:10.1002/ppul.20550 · Cited by 33
Brophy, P. D. (2008) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2008.05.005 · Cited by 33
Extracorporeal support for septic shock*
Bartlett, R. H. (2007) · Pediatric Critical Care Medicine · doi:10.1097/01.pcc.0000282163.60836.2c · Cited by 32
Metabolic Effects of Arginine Addition to the Enteral Feeding of Critically III Patients
Preiser, J., Berré, J., Gossum, A. V., Cynober, L., Vray, B., Carpentier, Y., & Vincent, J. (2001) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607101025004182 · Cited by 32
Self-citationBlood Glucose Variability: A New Paradigm in Critical Care?
Ouattara, A., Grimaldi, A., & Riou, B. (2006) · Anesthesiology · doi:10.1097/00000542-200608000-00002 · Cited by 32
Mauritz, W., Sporn, P., Schindler, I., Zadrobilek, E., Roth, E., & Appel, W. (1986) · PubMed · Cited by 31
Barie, P. S., Hydo, L. J., Shou, J., & Eachempati, S. R. (2006) · Surgical Infections · doi:10.1089/sur.2006.7.s2-77 · Cited by 30
Verhoeven, J. J., den Brinker, M., Hokken-Koelega, A., Hazelzet, J. A., & Joosten, K. F. M. (2011) · Critical Care · doi:10.1186/cc10006 · Cited by 29
Checkley, W. (2011) · JAMA · doi:10.1001/jama.2011.1504 · Cited by 28
groups, T. S. S., Cuthbertson, B. H., Francis, J., Campbell, M., MacIntyre, L. M., Seppelt, I., & Grimshaw, J. (2010) · Trials · doi:10.1186/1745-6215-11-117 · Cited by 28
Knowledge translation and the multifaceted intervention in the intensive care unit
Black, M. D., Schorr, C., & Levy, M. M. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e3182431673 · Cited by 27
Self-citationRodríguez‐Núñez, A., Erroz, I. O., Gil-Antón, J., Pérez-Caballero, C., López‐Herce, J., Gaboli, M. P., & Milano, G. (2010) · Annals of Pharmacotherapy · doi:10.1345/aph.1p254 · Cited by 27
Surgical treatment of pediatric lung abscess
Wu, M., Tseng, Y., Mu, L., & Wo‐Wei, L. A. I. (1997) · Pediatric Surgery International · doi:10.1007/bf01372153 · Cited by 25
Provision of Balanced Nutrition Protects Against Hypoglycemia in the Critically Ill Surgical Patient
Kauffmann, R. M., Hayes, R. M., Jenkins, J. M., Norris, P. R., Diaz, J. J., May, A. K., & Collier, B. R. (2011) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607111413904 · Cited by 25
Adrenal function in sepsis and septic shock
Pizarro, C. F., & Troster, E. J. (2007) · Jornal de Pediatria · doi:10.2223/jped.1708 · Cited by 25
Sonoclot coagulation analysis and plasma exchange in a case of meningococcal septicaemia
Schött, U., & Björsell-Östling, E. (1995) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/bf03010573 · Cited by 24
Guerin, C., Gaillard, S., Lemasson, S., Ayzac, L., Girard, R., Beuret, P., Palmier, B., Le, Q. V., Sirodot, M., Rosselli, S., et al. (2004) · JAMA · doi:10.1001/jama.292.19.2379 · Cited by 24
Pharmacokinetics and Pharmacodynamics of Anti-infective Agents
Pai, M. P., Cottrell, M. L., Kashuba, A. D. M., & Bertino, J. (2015) · Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases · doi:10.1016/b978-1-4557-4801-3.00019-9 · Cited by 24
Peritonitis in childhood: aspects of pathogenesis and therapy
Haecker, F.-M., Berger, D., Schumacher, U., Friess, D., & Schweizer, P. (2000) · Pediatric Surgery International · doi:10.1007/s003830050719 · Cited by 21
Recommendations for the Use of Therapeutic Plasma
Heim, M. U., Meyer, B., & Hellstern, P. (2009) · Current Vascular Pharmacology · doi:10.2174/157016109787455671 · Cited by 21
Plasma exchange and haemodiafiltration in fulminant meningococcal sepsis.
Kumar, A., Kanagasundaram, N. S., Collyns, T. A., & Davison, A. M. (1998) · Nephrology Dialysis Transplantation · doi:10.1093/oxfordjournals.ndt.a027853 · Cited by 20
Antithrombin concentrate with plasma exchange in purpura fulminans
Munteanu, C., Bloodworth, L. L. O., & Korn, T. H. E. (2000) · Pediatric Critical Care Medicine · doi:10.1097/00130478-200007000-00016 · Cited by 20
Current treatment of severe sepsis
Cinel, İ., & Dellinger, R. P. (2006) · Current Infectious Disease Reports · doi:10.1007/s11908-006-0046-0 · Cited by 19
Self-citationTreatment Strategies for Methicillin-Resistant Staphylococcus aureus Infections in Pediatrics
Newland, J. G., & Kearns, G. L. (2008) · Pediatric Drugs · doi:10.2165/0148581-200810060-00004 · Cited by 19
A silent killer: Cytomegalovirus infection in the nonimmunocompromised critically ill patient*
Kalil, A. C. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e31818f24c3 · Cited by 18
El‐Nawawy, A. (2004) · Journal of Tropical Pediatrics · doi:10.1093/tropej/50.6.339 · Cited by 18
Nichols, J. H. (2002) · CRC Press eBooks · doi:10.1201/b14092 · Cited by 16
Jiang, H., Chen, W., Hu, W., Cai, B., & Liao, R.-J. (2009) · PubMed · Cited by 15
Streptococcal Fasciitis With Toxic Shock Syndrome in the Pediatric Patient
Jackson, M. A., Colombo, J. M., & Boldrey, A. (2003) · Orthopaedic Nursing · doi:10.1097/00006416-200301000-00004 · Cited by 14
Flagg, A., Danziger‐Isakov, L. A., Foster, C. B., Nasman, C., Smedira, N. G., Carl, J. C., Kwon, C., Davis, S., & Boyle, G. (2010) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2009.11.600 · Cited by 14
[Community-acquired Staphylococcus aureus bacteremia: 17 years of experience in Argentine children].
Paganini, H. R., Latta, P. D., Soto, A., Casimir, L., Monaco, A. L., Verdaguer, V., Berberián, G., Rosanova, M. T., González, F., & Sarkis, C. (2010) · PubMed · doi:10.1590/s0325-00752010000400004 · Cited by 11
Observational case-control study of non-invasive ventilation in patients with ARDS
Domenighetti, G. M., Moccia, A. A., & Gayer, R. (2016) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2008.405 · Cited by 11
Plastic Surgery Management of Soft Tissue Loss in Meningococcal Septicemia
Penington, A., Craft, R. O., & Tilkorn, D. J. (2007) · Annals of Plastic Surgery · doi:10.1097/01.sap.0000237642.46000.e6 · Cited by 10
Tian, H., Wang, K.-F., & Wu, T. (2006) · PubMed · Cited by 9
Fortenberry, J. D. (2008) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2008.05.004 · Cited by 7
Alteraciones del sistema de la coagulación y la fibrinólisis en el shock séptico asociado a púrpura
Miralles, A. S., Saenz, R. R., Vera, P. M., Pérez, F. M., Sánchez, B., & Muñoz, I. S. (2002) · Anales de Pediatría · doi:10.1016/s1695-4033(02)78938-8 · Cited by 6
Tuğrul, S., Özcan, P. E., Akıncı, İ. Ö., İsmailov, M., Çağatay, A., Çakar, N., & Esen, F. (2004) · PubMed · Cited by 4
Tratamiento del shock séptico con plasmafiltración y hemodiafiltración continuas simultáneas
Cid, J. L.-H., Arriortua, A. B., Romero, A. J. A., Brandstrup, K. B., García-Abril, C. F., & Rubio, M. R. (2003) · Anales de Pediatría · doi:10.1016/s1695-4033(03)78765-7 · Cited by 3
Cited by
The third international consensus definitions for sepsis and septic shock (Sepsis-3).
Singer, M., Deutschman, C. S., Seymour, C. W., Shankar-Hari, M., Annane, D., Bauer, M., Bellomo, R., Bernard, G. R., Chiche, J.-D., Coopersmith, C. M., et al. (2016) · JAMA · doi:10.1001/jama.2016.0287 · Cited by 28,250
Self-citationIntravenous Fluids and Acute Kidney Injury
Ding, X., Cheng, Z., & Qian, Q. (2017) · Blood Purification · doi:10.1159/000452702 · Cited by 6,827
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4683-6 · Cited by 6,621
Self-citationSurviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Self-citationHabib, G., Lancellotti, P., Antunes, M. J., Bongiorni, M. G., Casalta, J.-P., Del Zotti, F., Dulgheru, R., El Khoury, G., Erba, P. A., Iung, B., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv319 · Cited by 4,997
Metadata
- Authors
- The Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup*, Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., Osborn, T. M., Nunnally, M. E., Townsend, S. R., Reinhart, K., Kleinpell, R. M., Angus, D. C., Deutschman, C. S., Machado, F. R., Rubenfeld, G. D., Webb, S., Beale, R. J., Vincent, J.-L., & Moreno, R.
- Venue
- Intensive Care Medicine
- Published
- 2013-01-30
- Volume
- 39
- Issue
- 2
- Pages
- 165-228
- ISSN
- 0342-4642 (ISSN-L)
- 1432-1238
- OpenAlex
- W2442246762
- Cited by
- 7,290
- References
- 674
- FWCI
- 764.03
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.